What Theravance Biopharma, Inc.'s executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.
| 3 months | 12 months | |
|---|---|---|
| Open-market buys | 0 | 0 |
| Sells | 3 | 22 |
| Total trades | 34 | 80 |
| 3 months | 12 months | |
|---|---|---|
| Acquired | 0 | 0 |
| Disposed | 0 | 0 |
| Net activity | +0 | +0 |
Common stock only — 80 reported trades in the last 12 months are in a security these totals do not cover.
View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.
| Insider | Relation | Date | Transaction | Shares | Price | Value | Shares held |
|---|---|---|---|---|---|---|---|
| Weiss Asset Management Lp | Insider | Sep 23 | Other Transaction · J | −7,457,060 | $17.00 | −$127M | 0 |
| Smaldone Alsup Laurie | Director | Sep 23 | Disposition to Issuer · D | −6,009 | — | — | 0 |
| Smaldone Alsup Laurie | Director | Sep 23 | Disposition to Issuer · D | −74,980 | — | — | 6,009 |
| Mitchell Dean J | Director | Sep 23 | Disposition to Issuer · D | −6,009 | — | — | 0 |
| Mitchell Dean J | Director | Sep 23 | Disposition to Issuer · D | −91,204 | — | — | 6,009 |
| O'Connor Donal | Director | Sep 23 | Disposition to Issuer · D | −6,009 | — | — | 0 |
| O'Connor Donal | Director | Sep 23 | Disposition to Issuer · D | −74,204 | — | — | 6,009 |
| Grimaud Brett A. | SVP, GEN COUNSEL AND SECRETARY | Sep 23 | Disposition to Issuer · D | −23,439 | — | — | 0 |
| Grimaud Brett A. | SVP, GEN COUNSEL AND SECRETARY | Sep 23 | Disposition to Issuer · D | −107,812 | — | — | 23,439 |
| Grimaud Brett A. | SVP, GEN COUNSEL AND SECRETARY | Sep 23 | Disposition to Issuer · D | −223,917 | — | — | 131,251 |
| Farnum Rhonda | SVP, COMM & MEDICAL AFFAIRS | Sep 23 | Disposition to Issuer · D | −89,062 | — | — | 0 |
| Farnum Rhonda | SVP, COMM & MEDICAL AFFAIRS | Sep 23 | Disposition to Issuer · D | −124,414 | — | — | 89,062 |
| Gray Susannah | Director | Sep 23 | Disposition to Issuer · D | −6,009 | — | — | 0 |
| Gray Susannah | Director | Sep 23 | Disposition to Issuer · D | −42,137 | — | — | 6,009 |
| Sawaf Aziz | SVP & CHIEF FINANCIAL OFFICER | Sep 23 | Disposition to Issuer · D | −23,439 | — | — | 0 |
| Sawaf Aziz | SVP & CHIEF FINANCIAL OFFICER | Sep 23 | Disposition to Issuer · D | −108,436 | — | — | 23,439 |
| Sawaf Aziz | SVP & CHIEF FINANCIAL OFFICER | Sep 23 | Disposition to Issuer · D | −204,966 | — | — | 131,875 |
| Pakianathan Deepika | Director | Sep 23 | Disposition to Issuer · D | −6,009 | — | — | 0 |
| Pakianathan Deepika | Director | Sep 23 | Disposition to Issuer · D | −58,065 | — | — | 6,009 |
| Winningham Rick E | CHIEF EXECUTIVE OFFICER | Sep 23 | Disposition to Issuer · D | −92,567 | — | — | 0 |
Loading...